Latest updates for Drug Supply Chain Security Act
Fresh curated links around Drug Supply Chain Security Act are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- <![CDATA[What Best-In-Class Supply Chain Data Infrastructure Looks Like Today: LogiPharma 2026]]>
- The paperwork problem: How many FDA warning letters actually cite document failures
- A Quantifiable 3D Closed-Loop Framework for Controlled Substance Safety in a HIMSS Electronic Medical Record Adoption Mo
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The paperwork problem: How many FDA warning letters actually cite document failures
When people take a medication, they trust that it contains the right amount of active ingredient and is free of harmful contamination. Manufacturing and test records help verify th...
A Quantifiable 3D Closed-Loop Framework for Controlled Substance Safety in a HIMSS Electronic Medical Record Adoption Mo...
Background: Controlled substances require strict life cycle management, but manual workflows can lead to documentation errors, traceability gaps, and delays in empty-ampoule recove...
Top Ten Essentials for Preventing Hospital Controlled Substance Diversion
By Larry K. Houck —
<![CDATA[Where Most Pharma Companies Still Have Meaningful Gaps in Their Supply Chains: LogiPharma 2026]]>
CBP Considers Deeper Supply Chain Disclosures; Comments Due December 1, 2026
Dietary Supplement Innovation Act Aims to Address Drug Preclusion Concerns
Representative Diana Harshbarger (R-TN) recently introduced the Dietary Supplement Innovation Act (H.R. 10336), legislation that would amend the Federal Food, Drug, and Cosmetic Ac...
Preorder DCI’s New 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
On October 12, 2026, Drug Channels Institute will release our 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. The U.S. prescription drug marke...
NOW AVAILABLE: DCI’s New 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
Drug Channels Institute is pleased to announce the availability of our 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. The U.S. prescription d...
Missouri Joins 20-state coalition alerting National Security Council to pharmaceuticals exploited by Chinese supply chai...
The letter identifies national security risks from dangerous pharmaceutical ingredients used in popular compounded GLP-1 drugs,
<![CDATA[How ClaimGuardRx's Purpose-Built AI Detects and Counters Diversion Tactics]]>
<![CDATA[Waiting for Perfect Data Is the Biggest Mistake in Pharma Supply Chains]]>
NAFDAC Assures Nigerians of Safety Checks on All US-Nigeria Medical Supplies
• Deploys track-and-trace technology to monitor distribution of medicines and vaccines nationwide Sunday Ehigiator The National Agency for Food and Drug Administration and Control...
CID, FDA strengthen collaboration to combat illicit drugs and counterfeit products
The Criminal Investigations Department (CID) of the Ghana Police Service has engaged the Food and Drugs Authority (FDA) to strengthen cooperation in the fight against illicit drugs...
<![CDATA[How Can Restricting Compounded Peptides Affect Current Gray Market Users?]]>
<![CDATA[The Impact That the Renewed Focus on Domestic Manufacturing Might Have on the Supply Chain]]>
3 Ways PK PD Data Analysis Impacts Pharma Logistics!
Behind every drug in the market—whether prescription or over-the-counter—are years of painstaking research and development. A 2024 study of over 80 projects published in The Lancet...
4 Steps to Secure the Healthcare Data Supply Chain!
Data security has become a major concern over the last few years. It’s the responsibility of every sector, including the Healthcare Data Supply Chain, to ensure they secure their s...
<![CDATA[What Supply Chain Resilience Actually Requires in a Volatile Global Market: LogiPharma2026]]>
<![CDATA[The Manufacturing Issues That Continue to Contribute to Drug Shortages]]>
Proposed H.R. 10336 Would Balance Innovation, Access to Dietary Supplements—Yet Change the Definition
On September 10, 2026, Congresswoman Diana Harshbarger (R-TN) introduced H.R. 10336—the Dietary Supplement Innovation Act—which would modernize the U.S. Food and Drug Administratio...
Trade Associations Applaud Dietary Supplement Innovation Act
On Sept. 10, Congresswoman Diana Harshbarger (R-TN) introduced the Dietary Supplement Innovation Act, legislation that is designed to modernize the Food and Drug Administration’s d...
Extractables in single-use systems used in ADC manufacturing
Explore extractables data supporting single-use systems in ADC manufacturing.
D.C. Circuit Upholds Anthropic FASCSA Designation and Endorses Broad Interpretation of Supply-Chain Risk
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.